Our study suggests that Methanobrevibacter may contribute to an increased risk of nasal polyps by affecting the levels of CCR2 on CD62L+ myeloid dendritic cells and CD3 on CD4 regulatory T cells. This evidence concerns the gene SELL and nasal cavity polyp.